1.Centers for Disease Control and Prevention. National and State Healthcare Associated Infections Progress Report. In: Division of Healthcare Quality Promotion NCEZID. Atlanta, GA: Centers for Disease Control and Prevention; 2016.
3.Leekha, S, Li, S, Thom, KA, et al. Comparison of total hospital-acquired bloodstream infections to central line-associated bloodstream infections and implications for outcome measures in infection control. Infect Control Hosp Epidemiol 2013;34:984–986.
4.Rock, C, Thom, KA, Harris, AD, et al. A multicenter longitudinal study of hospital-onset bacteremia: time for a new quality outcome measure? Infect Control Hosp Epidemiol 2016;37:143–148.
5.Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–2732.
6.Blijlevens, NM, Donnelly, JP, De Pauw, BE.Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transpl 2000;25:1269–1278.
7.Linsenmeyer, K, Gupta, K, Strymish, JM, Dhanani, M, Brecher, SM, Breu, AC. Culture if spikes? Indications and yield of blood cultures in hospitalized medical patients. J Hosp Med 2016;11:336–340.
8.Alahmadi, YM, Aldeyab, MA, McElnay, JC, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect 2011;77:233–236.
9.Waltzman, ML, Harper, M. Financial and clinical impact of false-positive blood culture results. Clin Infect Dis 2001;33:296–299.
10.Towns, ML, Jarvis, WR, Hsueh, PR. Guidelines on blood cultures. J Microbiol Immunol Infect 2010;43:347–349.